We have final cohort announcement either next week or the week after then we move on too AGN results which will solidify a drug safety in humans and de risks the mechanism of action
For AGN CEO to say they will look at synergies and combine with NYR for treating secondary brain injury and provide cardio protection tells you how undervalued a 30 million market cap when AGN is a 110 million market cap ready to rerate in the next 1-2 months
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.025(10.6%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 26.5¢ | 23.5¢ | $352.7K | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3600 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 4499 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |